Co-culturing CTLA-4+ BC cells with human dendritic cells (DCs) inhibits extracellular signal-regulated kinase and activating transcription factor 3 (ATF3), suppressing DC function and maturation (42). The gene discussed is CTLA4; the disease is breast cancer.